Qi Deng

792 total citations
67 papers, 548 citations indexed

About

Qi Deng is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Qi Deng has authored 67 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 15 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Qi Deng's work include CAR-T cell therapy research (39 papers), Immune Cell Function and Interaction (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). Qi Deng is often cited by papers focused on CAR-T cell therapy research (39 papers), Immune Cell Function and Interaction (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). Qi Deng collaborates with scholars based in China, United States and Saint Kitts and Nevis. Qi Deng's co-authors include Qing Li, Meijing Liu, Yanyu Jiang, Rui Cui, Juan Mu, Mingfeng Zhao, Haibo Zhu, Jia Wang, Cuicui Lyu and Bo Wei and has published in prestigious journals such as Blood, Clinical Cancer Research and Frontiers in Immunology.

In The Last Decade

Qi Deng

55 papers receiving 538 citations

Peers

Qi Deng
Qi Deng
Citations per year, relative to Qi Deng Qi Deng (= 1×) peers Lucía Fernández

Countries citing papers authored by Qi Deng

Since Specialization
Citations

This map shows the geographic impact of Qi Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Deng more than expected).

Fields of papers citing papers by Qi Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Deng. The network helps show where Qi Deng may publish in the future.

Co-authorship network of co-authors of Qi Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Deng. A scholar is included among the top collaborators of Qi Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Deng. Qi Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Dianwu, Rui Zhang, Cheng Lü, et al.. (2025). Influence mechanism of beam oscillation on energy density distribution and mechanical properties of steel/CFRP joint by direct laser welding. Composite Structures. 363. 119133–119133.
2.
Cheng, Jie, Qi Deng, Wei Lin, et al.. (2025). Inhibition of GRK2 mitigates renal fibrosis via oxidative stress pathway. European Journal of Pharmacology. 1003. 177887–177887.
3.
Deng, Qi, Feng Li, Lianhua Bai, et al.. (2025). The Effects of Different Bimaxillary Orthognathic Surgery Sequencing on the Temporomandibular Joint Space of Skeletal Class II Malocclusion Patients. Journal of Oral and Maxillofacial Surgery. 83(10). 1233–1243.
4.
Mu, Juan, Rui Cui, Xin Li, et al.. (2024). Efficacy and side effects of anti‐CD19 CAR T‐cell therapy in patients with relapsed/refractory gastrointestinal lymphoma. Cancer Medicine. 13(4). e7064–e7064. 1 indexed citations
5.
Deng, Qi, et al.. (2023). Enhancing Network by Reinforcement Learning and Neural Confined Local Search. 2122–2132. 2 indexed citations
6.
Liu, Hong, et al.. (2023). Blinatumomab as salvage therapy in patients with relapsed/refractory B-ALL who have failed/progressed after anti-CD19-CAR T therapy. Annals of Medicine. 55(1). 2230888–2230888. 7 indexed citations
7.
Liu, Meijing, Cuicui Lv, Lan Chen, et al.. (2022). Synergistic Effects of Zanubrutinib Combined With CD19 CAR-T Cells in Raji Cells in Vitro and in Vivo. Technology in Cancer Research & Treatment. 21. 2213875112–2213875112. 3 indexed citations
8.
Liu, Lu, et al.. (2021). Development of a biomechanical model for dynamic occlusal stress analysis. International Journal of Oral Science. 13(1). 29–29. 11 indexed citations
11.
12.
Jia, Lin, Qi Deng, Yuguan Wen, et al.. (2021). Role of serum amitriptyline concentration and CYP2C19 polymorphism in predicting the response to low-dose amitriptyline in irritable bowel syndrome. Digestive and Liver Disease. 53(11). 1422–1427. 1 indexed citations
13.
Liu, Meijing, Ting Yuan, Huan Zhang, et al.. (2021). Efficacy of Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With and Without Extramedullary Disease. Frontiers in Immunology. 12. 720571–720571. 36 indexed citations
14.
Liu, Meijing, Xuelin Wang, Zheng Li, et al.. (2020). Synergistic effect of ibrutinib and CD19 CAR‐T cells on Raji cells in vivo and in vitro. Cancer Science. 111(11). 4051–4060. 20 indexed citations
15.
Liu, Meijing, Cuicui Lyu, Wenyi Lu, et al.. (2020). Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant. Frontiers in Oncology. 10. 573822–573822. 39 indexed citations
18.
Deng, Qi, et al.. (2020). Acute Effect of Transcutaneous Electroacupuncture on Globus Pharyngeus: A Randomized, Single-Blind, Crossover Trial. Frontiers in Medicine. 7. 179–179. 3 indexed citations
20.
Zhao, Mingfeng, Nan Zhao, Wenyi Lu, et al.. (2013). Multiple Cytotoxic Factors Involved in IL-21 Enhanced Antitumor Function of CIK Cells Signaled through STAT-3 and STAT5b Pathways. Asian Pacific Journal of Cancer Prevention. 14(10). 5825–5831. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026